Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
Yena Lee, Rodrigo B. Mansur, Elisa Brietzke, Nicole E. Carmona, Mehala Subramaniapillai, Zihang Pan, Margarita Shekotikhina, Joshua D. Rosenblat, Trisha Suppes, Victoria E. Cosgrove, Nicole E. Kramer, Roger S. McIntyre
Topics & Concepts
InfliximabMedicinePlaceboInternal medicineAdjunctive treatmentAnhedoniaRandomized controlled trialGastroenterologyTumor necrosis factor alphaDopaminePathologyAlternative medicineTryptophan and brain disordersBipolar Disorder and TreatmentAdolescent and Pediatric Healthcare